Michael L Wong, MD
Radiation Oncology · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Wong’s office at (408) 851-8000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A131114 · Current
Licensed to practise in California · since 2014 · expires 2027-09-30 · Drexel University College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$1,156
Pharmacies billed $1,156 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 66) in 2024. At or below the middle of the specialty; the typical radiation oncology clinician is at 11%.
66 generic and 0 brand-name prescriptions · $1,156 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gavilyte-C | 19 | $515 | $22 |
| Tamsulosin | 13 | $382 | $13 |
Year by year
| 2024 | 66 | 36 | 0% (0) | 0% | $1,156 |
| 2023 | 98 | 47 | 0% (0) | None | $1,701 |
| 2022 | 142 | 55 | None | None | $2,534 |
| 2021 | 112 | 38 | 0% (0) | None | $2,194 |
| 2020 | 242 | 72 | None | None | $3,969 |
| 2019 | 341 | 98 | 0% (0) | None | $6,909 |
| 2018 | 324 | 89 | None | 10% | $7,122 |
| 2017 | 353 | 110 | None | None | $10,558 |
| 2016 | 128 | 72 | 15% (19) | None | $3,219 |
| 2015 | 17 | None | None | None | $1,980 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Gavilyte-C | 24 | $485 | $20 |
| Tamsulosin | 38 | $475 | $13 |
2022: 3 drugs
| Tamsulosin | 89 | $1,057 | $12 |
| Dexamethasone | 15 | $395 | $26 |
| Gavilyte-C | 15 | $269 | $18 |
2021: 1 drug
| Tamsulosin | 98 | $1,248 | $13 |
2020: 3 drugs
| Tamsulosin | 173 | $2,377 | $14 |
| Gavilyte-C | 21 | $381 | $18 |
| Bicalutamide | 12 | $124 | $10 |
2019: 4 drugs
| Tamsulosin | 220 | $3,167 | $14 |
| Gavilyte-C | 37 | $1,310 | $35 |
| Dexamethasone | 19 | $339 | $18 |
| Bicalutamide | 17 | $181 | $11 |
2018: 5 drugs
| Tamsulosin | 163 | $2,223 | $14 |
| Gavilyte-C | 30 | $1,086 | $36 |
| Peg 3350-Electrolyte | 17 | $647 | $38 |
| Dexamethasone | 21 | $465 | $22 |
| Bicalutamide | 16 | $213 | $13 |
2017: 4 drugs
| Tamsulosin | 188 | $2,725 | $14 |
| Gavilyte-C | 73 | $1,253 | $17 |
| Bicalutamide | 19 | $331 | $17 |
| Dexamethasone | 12 | $227 | $19 |
2016: 4 drugs
| Tamsulosin | 38 | $890 | $23 |
| Hydrocodone-Acetaminophen | 17 | $668 | $39 |
| Bicalutamide | 18 | $338 | $19 |
| Gavilyte-C | 16 | $284 | $18 |
Money from drug and device companies
$203 in 2025
| 2025 | 1 | 3 | None | $203 |
| 2022 | 1 | 1 | None | $22 |
| 2021 | 1 | 2 | None | $46 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Siemens Medical Solutions USA | Truebeam | $203 | 3 payments
|
See all 3 published payments
| Siemens Medical Solutions USA | Meals · 2025-11-24 | None | $174 |
| Siemens Medical Solutions USA | Meals · 2025-10-30 | Truebeam | $18 |
| Siemens Medical Solutions USA | Meals · 2025-03-10 | Truebeam | $11 |
See earlier years (2022, 2021)
2022: $22
| Grifols USA | Xembify | $22 | 1 payment
|
2021: $46
| Grifols USA | Prolastin-C Liquid | $46 | 2 payments
|
Professional record
- NPI
- 1649505975
- Licence
- CA A131114, PA MT196247California A131114: Current · expires 2027-09-30
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 2085R0001X (2085R0001X); Internal medicine (207R00000X)
- Mailing address
- 200 UCLA Medical Plz, Suite B265, Los Angeles, CA, 90095
- NPI first listed
- 2009-10-05
- NPI last updated
- 2022-02-11
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.